Daftar Publikasi Ilmiah Terkait Covid-19 (List of Scientific Publications related to Covid-19)

Ilustrasi peneliti yang mencari vaksin Covid-19

Berikut daftar publikasi ilmiah terkait dengan Covid-19 (Bat Coronavirus, SARS-Cov-2). Publikasi yang ada didalam daftar dikumpulkan dari berbagai sumber, baik Jurnal Ilmiah atau publikasi resmi lainnya. Hal ini saya lakukan dengan tujuan memberikan kemudahan akses informasi terkait Covid-19. Semoga dengan adanya akses ini, maka kejadian miss-informasi dapat ditekan dan dapat membantu orang-orang yang ingin mencari tau tentang Covid-19.

Kabar Terbaru Terkait Jumlah Pasien Positif Covid-19 bisa dilihat disini.

Indonesian References

1. Protokol Pintu Masuk Wilayah Indonesia (Bandara, Pelabuhan, PLBDN) (lihat)

2. Pedoman Kesiapsiagaan Menghadapi Coronavirus Disease (lihat)

Scientific Journal Paper

1. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study (lihat)

2. Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study (lihat)

3. Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study (lihat)

4. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China (lihat)

5. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster (lihat)

6. First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA (lihat)

7. Early dynamics of transmission and control of COVID-19: a mathematical modelling study (lihat)

8. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study (lihat)

9. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts (lihat)

10. COVID-19 and Italy: what next? (lihat)

11. The psychological impact of quarantine and how to reduce it: rapid review of the evidence (lihat)

12. Pathological findings of COVID-19 associated with acute respiratory distress syndrome (lihat)

13. Can we contain the COVID-19 outbreak with the same measures as for SARS? (lihat)

14. History in a Crisis — Lessons for Covid-19 (lihat)

15. Clinical Characteristics of Coronavirus Disease 2019 in China (lihat)

16. Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China (lihat)

17. A Locally Transmitted Case of SARS-CoV-2 Infection in Taiwan (lihat)

18. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia (lihat)

19. Probable pangolin origin of SARS-CoV-2 associated with theCOVID-19 outbreak (lihat)

20. A sequence homology and bioinformatic approach can predictcandidate targets for immune responses to SARS-CoV-2 (lihat)

21. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China (lihat)

22. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein (lihat)

23. COVID-19: epidemiology, evolution, and cross-disciplinary1perspectives (lihat)

24. Bat-Origin Coronaviruses Expand Their Host Range to Pigs (lihat)

25. Betacoronavirus Adaptation to Humans Involved Progressive Loss of Hemagglutinin-Esterase Lectin Activity (lihat)

26. Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics (lihat)

27. Arguments in favor of remdesivir for treating SARS-CoV-2 infections (lihat)

28. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (lihat)

29. Remdesivir as a possible therapeutic option for the COVID-19 (lihat)

30. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 (lihat)

31. Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy (lihat)

32. Association between 2019-nCoV transmission and N95 respirator use (lihat)

33. Ophthalmologists Are More Than Eye Doctors—In Memoriam Li Wenliang (lihat)

34. The Novel Coronavirus 2019 Epidemic and Kidneys (lihat)

35. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) (lihat)

36. The novel Coronavirus (SARS-CoV-2) is a one health issue (lihat)

37. Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know (lihat)

38. Novel coronavirus disease (Covid-19): The first two patients in the UK with person to person transmission (lihat)

39. Integrated infection control strategy to minimize nosocomial infection of corona virus disease 2019 among ENT healthcare workers (lihat)

40. The non-contact handheldcutaneous infra-red thermometerfor fever screening during theCOVID-19 global emergency (lihat)

41. Novel coronavirus, poor quarantine, and the risk ofpandemic (lihat)

42. Novel coronavirus is putting the whole world on alert (lihat)

43. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges (lihat)

44. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2) (lihat)

45. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2 (lihat)

46. First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan (lihat)

47. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future (lihat)

48. The association between domestic train transportation and novel coronavirus (2019-nCoV) outbreak in China from 2019 to 2020: A data-driven correlational report (lihat)

49. Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine (lihat)

50. More Effective Strategies are Required to Strengthen Public Awareness of COVID-19: Evidence from Google Trends (lihat)

51. Visualizing the Novel Coronavirus (COVID-19) in Children: What We Learn from Patients at Wuhan Children's Hospital (lihat)

52. Precautions Are Needed for COVID-19 Patients with Coinfection of Common Respiratory Pathogens (lihat)

53. Mathematical Recommendations to Fight Against COVID-19 (lihat)

54. Diagnosis and Management of First Case of COVID-19 in Canada: Lessons applied from SARS (lihat)

55. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19) (lihat)

56. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series (lihat)

57. Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia (lihat)

58. Imaging changes in patients with 2019-nCov (lihat)

59. A pneumonia outbreak associated with a new coronavirus of probable bat origin (lihat)

60. Survey of Insomnia and Related Social Psychological Factors Among Medical Staffs Involved with the 2019 Novel Coronavirus Disease Outbreak (lihat)

61. Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 (lihat)

62. Positive result of Sars-Cov-2 in sputum from a cured patient with COVID-19 (lihat)

63. Serial interval in determining the estimation of reproduction number of the novel coronavirus disease (lihat)

64. Chest computed tomography in children with COVID-19 respiratory infection (lihat)

65. Novel Coronavirus (COVID‐19) Epidemic: What Are the Risks for Older Patients? (lihat)

66. Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore (lihat)

67. The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase (lihat)

68. The establishment of reference sequence for SARS‐CoV‐2 and variation analysis (lihat)

69. Initial clinical features of suspected Coronavirus Disease 2019 in two emergency departments outside of Hubei, China (lihat)

70. Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta‐analysis (lihat)

71. Surveillance and Taxonomic Analysis of the Coronavirus Dominant in Pigeons in China (lihat)

72. A report of clinical diagnosis and treatment of 9 cases of coronavirus disease 2019 (lihat)

73. 2019 novel coronavirus patients’clinical characteristics,discharge rate and fatality rate of meta-analysis (lihat)

74. Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds (lihat)

75. Co‐infection of SARS‐CoV‐2 and HIV in a patient in Wuhancity, China (lihat)

76. From SARS and MERS CoVs to SARS-CoV-2: movingtoward more biased codon usage in viral structuraland non-structuralgenes (lihat)

77. Clinical implications of aminotransferase elevation in hospitalised infants aged 8-90 days with respiratory virus detection (lihat)

78. COVID-19: Emerging compassion, courage and resilience in the face of misinformation and adversity (lihat)

79. An outbreak of COVID-19 caused by a new coronavirus: what we know so far (lihat)

80. The ongoing crises in China indicate that the assessment of epidemics in isolation is no longer sufficient (lihat)

81. The transmission and diagnosis of 2019 novel coronavirusinfection disease (COVID‐19): A Chinese perspective (lihat)

82. Transmission dynamics of the COVID-19outbreak and effectivenessof government interventions: A data-driven analysis (lihat)

83. Emergency management for preventing and controlling nosocomial infection of 2019 novel coronavirus: implications for the dermatology department (lihat)

84. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis (lihat)

85. SARS-like virus in the Middle East: A truly bat-related coronavirus causing human diseases (lihat)

86. A Review of Coronavirus Disease-2019 (COVID-19) (lihat)

87. Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats (lihat)

88. Emerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments (lihat)

89. Regulating wildlife conservation and food safety to prevent human exposure to novel virus (lihat)

90. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses (lihat)

91. What does “crisis” education look like? (lihat)

92. Coronavirus disinfection in histopathology (lihat)

93. No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2 (lihat)

94. 2019 novel coronavirus: an emerging global threat (lihat)

95. Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination (lihat)

96. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak (lihat)

97. Broad-spectrum coronavirus antiviral drug discovery (lihat)

98. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies (lihat)

99. The global spread of 2019-nCoV: a molecular evolutionary analysis (lihat)

100. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity (lihat)

101. Bat origin of human coronaviruses (lihat)

102. Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report (lihat)

103. Serial interval of novel coronavirus (COVID-19) infections (lihat)

104. The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines (lihat)

105. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods (lihat)

106. Applications of google search trends for risk communication in infectious disease management: A case study of COVID-19 outbreak in Taiwan (lihat)

107. Preliminary estimation of the novel coronavirus disease (COVID-19) cases in Iran: A modelling analysis based on overseas cases and air travel data (lihat)

108. Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19 (lihat)

109. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis (lihat)

110. Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression (lihat)

111. A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action (lihat)

112. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) (lihat)

113. Serial interval of novel coronavirus (COVID-19) infections (lihat)

114. Is the Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic? - lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future (lihat)

115. 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation (lihat)

116. The effectiveness of quarantine and isolation determine the trend of the COVID-19 epidemics in the final phase of the current outbreak in China (lihat)

117. Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak (lihat)

118. The Extent of Transmission of Novel Coronavirus in Wuhan, China, 2020 (lihat)

119. Understanding Unreported Cases in the COVID-19 Epidemic Outbreak in Wuhan, China, and the Importance of Major Public Health Interventions (lihat)

120. Insights into the Recent 2019 Novel Coronavirus (SARS‐CoV‐2) in Light of Past Human Coronavirus Outbreaks (lihat)

121. Bat Coronaviruses in China (lihat)

122. Entry of Scotophilus Bat Coronavirus-512 and Severe Acute Respiratory Syndrome Coronavirus in Human and Multiple Animal Cells (lihat)

123. Global Epidemiology of Bat Coronaviruses (lihat)

124. Paramyxo- and Coronaviruses in Rwandan Bats (lihat)

125. Return of the Coronavirus: 2019-nCoV (lihat)

126. Bats and Coronaviruses (lihat)

127. Discovery and Characterization of Novel Bat Coronavirus Lineages from Kazakhstan (lihat)

128. From SARS to MERS, Thrusting Coronaviruses into the Spotlight (lihat)

129. Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development (lihat)

130. Identification of a Novel Betacoronavirus (Merbecovirus) in Amur Hedgehogs from China (lihat)

131. Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China (lihat)

Data Driven Related to Covid-19

1. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis (lihat)

Impact on Economy

1. Coronavirus COVID-19: Facts and Insights (lihat)

2. How Is the World Responding to the 2019 Coronavirus Disease Compared with the2014 West African Ebola Epidemic? The Importance of China as a Player in theGlobal Economy (lihat)

3. The Global Macroeconomic Impactsof COVID-19:Seven Scenarios* (lihat)

4. Coronavirus: Potential Impact on Real Estate (lihat)

5. Assessment of COVID-19’s Impact on Small and Medium-Sized Enterprises (lihat)

6. The Economic Impact of the COVID-19 Outbreak on Developing Asia (lihat)

7. COVID-19: Gauging the Pandemic (lihat)

8. Coronavirus: The world economy at risk (lihat)

9. An Economic Pandemic:COVID-19 Recession 2020 (lihat)

Impact on Psychology

1. The psychological impact of quarantine and how to reduce it: rapid review of the evidence (lihat)

2. Mental Health and Psychosocial Considerations During COVID-19 Outbreak (lihat)

Postingan ini adalah wujud kepedulian saya terhadap upaya pengurangan dampak penyebaran Covid-19, khususnya untuk memberikan akses informasi kemapa khalayak luas. (This post is an expression of my concern to the attempt of impact reduction of Covid-19 spreads, especially for giving information access to the peoples.)

____

Salam #sobatsambat

Jangan lupa Like, Subscribe dan Share artikel ini kalau kalian suka ya.

(Halah kok malah koyok Youtuber wae c@k, iki lho cuma blog tok, rasah kakean polah, wkwkwkwk)

____

RBS, March 2020